학술논문
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study
Document Type
Article
Author
Fisher, Benjamin A; Szanto, Antonia; Ng, Wan-Fai; Bombardieri, Michele; Posch, Maximilian G; Papas, Athena S; Farag, Arwa M; Daikeler, Thomas; Bannert, Bettina; Kyburz, Diego; Kivitz, Alan J; Carsons, Steven E; Isenberg, David A; Barone, Francesca; Bowman, Simon J; Espié, Pascal; Floch, David; Dupuy, Cyrielle; Ren, Xiaohui ; Faerber, Petra M; Wright, Andrew M; Hockey, Hans-Ulrich; Rotte, Michael; Milojevic, Julie; Avrameas, Alexandre; Valentin, Marie-Anne; Rush, James S; Gergely, Peter
Source
In The Lancet Rheumatology March 2020 2(3):e142-e152
Subject
Language
ISSN
2665-9913